Table 3.

Univariate and multivariable analyses of T2D prognostic impact. F, female; L, left; M, male; R, right.

Co‐variate	Dichotomization	Median survivals	No. of events/patients	P at univariate	HR	95% CI	P at multivariate
Age	< 65 years vs ≥ 65 years	15.3 vs 12.6	42/95 vs 48/108	0.3141	1.22	0.75–1.99	0.4098
Gender	M vs F	13.6 vs 15.0	45/98 vs 45/105	0.7870	0.82	0.51–1.32	0.4276
Side	L vs R	15.3 vs 12.6	31/73 vs 59/130	0.3431	1.33	0.80–2.19	0.2584
Metastatic involvement	1 site vs > 1	27.3 vs 9.0	15/38 vs 75/165	0.0002	2.36	1.30–4.27	0.0043
Response to firs‐line CT	DC vs not DC	22.6 vs 8.6	43/107 vs 34/78	0.0005	0.50	0.30–0.82	0.0065
Glucose metabolism status	T2D vs not T2D	9.6 vs 17.3	21/41 vs 69/162	0.0197	2.01	1.11–3.64	0.0226